Lab Notes: Venatorx lands federal contract that could be worth up to $318M; Annovis Bio receives FDA approval to proceed with trial

This week's Lab Notes has updates from Venatorx and Kibow Biotech along with a new ranking of cell and gene therapy clusters, and more.